Epidemic response group to invest up to $384 mln in Novavax's COVID-19 vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. CRWV
10. NOW

Go back to Epidemic response group to invest up to $384 mln in Novavax's COVID-19 vaccine

Novavax (NVAX) PT Raised to $38 at Ladenburg Thalmann

May 12, 2020 8:19 AM EDT

Ladenburg Thalmann analyst Michael Higgins raised the price target on Novavax (NASDAQ: NVAX) to $38.00 (from $28.00) while maintaining a Buy rating.

The analyst commented, "Last night, Novavax announced its 1Q20 results, presenting a $0.58 loss per share, better than our estimate of -$0.77... More

Inovio Pharma (INO) Misses Q1 EPS by 4c, Revenues Miss

May 11, 2020 5:26 PM EDT

Inovio Pharma (NASDAQ: INO) reported Q1 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.33 million versus the consensus estimate of $1.91 million.

INOVIO's President and Chief Executive Officer Dr. J. Joseph Kim said, "INOVIO had a very productive first quarter, laying the foundation for a... More

Novavax (NVAX) Tops Q1 EPS by 20c, Revenues Beat

May 11, 2020 5:04 PM EDT

Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.58), $0.20 better than the analyst estimate of ($0.78). Revenue for the quarter came in at $3.38 million versus the consensus estimate of $1.74 million.

Our accomplishments to-date in 2020, including significant progress in our influenza and COVID19 vaccine programs, are the most... More